BIOLASE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1689 USD | -2.88% |
|
+16.40% | -84.95% |
Presentation Operator MessageOperator (Operator)Good day, and welcome to the BIOLASE First Qua...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse.
Calendar
2024-05-12
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.1689
USD
Average target price
1.633
USD
Spread / Average Target
+867.04%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -84.95% | 5.62M | |
| +11.73% | 226B | |
| +9.53% | 188B | |
| +14.63% | 137B | |
| +27.47% | 108B | |
| -0.04% | 63.19B | |
| +13.73% | 52.26B | |
| +4.86% | 51B | |
| +7.72% | 43.89B | |
| +7.86% | 38.07B |
- Stock Market
- Equities
- BIOL Stock
- News BIOLASE, Inc.
- Transcript : BIOLASE, Inc., Q1 2022 Earnings Call, May 12, 2022